Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

Exclusion Criteria

• •Subject has participated in a clinical trial within the past 30 days
• •Subject has participated in any PepsiCo trial within past 6 months
• •Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
• •Subject is allergic to alcohol or facial cleansing wipes
• •Subject has a history of anaphylaxis or severe allergic reactions
• •Subjects has a health condition or is taking medication that can be worsened by fluid restriction
• •Subject has asthma or other condition which breathing can become labored during exercise (EXERCISE session participants only)
• •Male subjects with a VO2max \< 42 ml/kg/min and females with a VO2max \< 38 ml/kg/min (EXERCISE session participants only)
• •Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.